Latest Audit News

Ava Risk Group expects FY2026 revenue around $29 million, below prior guidance, due to delayed orders mainly in the Middle East and North America. Despite this, sales intake exceeded revenue, underpinning a strong backlog and positive EBITDA.

Talga Group has signed a non-binding Letter of Intent with Japan’s Dainen Materials to supply its Talnode®-C battery anode from Sweden, aiming for a binding agreement by year-end. This deepens a five-year partnership and positions Talga in Japan’s demanding battery market.

Lotus Resources has completed key acid plant repairs at its Kayelekera uranium mine, targeting production restart in early August 2026 and steady-state output by late year. The company also formalised a binding commitment with Mercuria for a US$30 million prepayment facility amid ongoing funding negotiations.

Lux Copper Corp. Ltd reported a modest loss in its inaugural financial period while acquiring two Alaskan copper projects and preparing for a public listing with fresh leadership appointments.

Alfabs Australia has strengthened its financial footing in Q4 FY26, commissioning new mining equipment and cutting costs to reduce net debt and progress towards dividend reinstatement.

Kingsgate Consolidated has successfully restarted Plant 1 at its Chatree Gold Mine at around 50% capacity using a modified circuit while fast-tracking repairs to the Ball Mill. Mining operations continue uninterrupted, supporting ongoing production at Plant 2.

L1 Group’s funds under management climbed 12.4% in Q4 2026, buoyed by inflows into its Gold Fund IPO and Long Short strategies, while FY26 performance fees are set to reach up to $167 million.

Admiralty Resources has pushed its Mariposa Iron Ore Project into pre-production, completed initial shipments, and raised $7 million in a rights issue, while reporting a $4 million loss for FY25 amid ongoing operational and financial challenges.

Tamawood expects a 40% increase in FY26 profit before tax to $11.679 million, buoyed by improved cash reserves and operational resilience amid cost pressures.

Skellerup has raised its FY26 net profit after tax forecast to $64-$65 million, driven by robust demand in the US and New Zealand markets, improved supply chain conditions, and favourable currency and tariff impacts.

Cryosite Limited reported an 18% rise in FY2026 revenue to $16.7 million, with EBITDA growing 27% amid completed and ongoing facility expansions. The company aims to convert new capacity into client growth in FY2027.

Mesoblast Limited’s Ryoncil® posted US$36 million in Q4 revenue, driving a full-year total of US$115 million, exceeding initial forecasts. The FDA-approved stem cell therapy for pediatric graft-versus-host disease shows robust uptake across US pediatric centres.